Skip to content
Trial Eligibility
Menu

Cell Collection to Study Eye Diseases

NCT01432847

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: - Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macular Degeneration (AMD) all affect the retina, the light sensing area at the back of the eye. Doctors cannot safely obtain retinal cells to study these diseases. However, cells collected from hair follicles, skin, saliva, urine, and blood can be used for research. Researchers want to collect cells from people with Best disease, L-ORD, and AMD, and compare their cells with those of healthy volunteers.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Retinal Disease
  • AMD
  • Retinal Degeneration
  • Retinitis Pigmentosa

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
1 day to 120 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Eye Institute (NEI)
Last updated on ClinicalTrials.gov
September 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.